
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.

Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.

Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.

Opdivo found to improve overall survival compared with other leading cancer therapies.

Extrahepatic manifestations may be important clues in the diagnosis of hepatitis C infection.

Health care professionals can use app to access patient data through HIPAA-compliant dashboards on computers or tablets.

Pfizer and Allergan announce $160 billion merger, which is the second-largest in the healthcare industry's history and the largest to use a controversial tax-saving strategy.

Pharmacies are rated as some of the best places to receive top-notch customer service in America.

Tafinlar plus Mekinist found to improve overall survival in unresectable or metastatic BRAF-mutated melanoma.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses techniques specialty pharmacies can use to improve workflow and clinical activities in therapy management.

Effective therapies in liver transplant patients reduces HCV recurrence.

App developers need to ensure mHealth apps are HIPAA-compliant by design.

CMS aims to provide choice and competition for consumers and improve the consumer experience.

Patients treated with HIV therapy less likely to get infected with HBV.

In addition to facing the risk of fatal overdose, kidney disease, and pneumonia, heroin users also have a greater likelihood of acquiring HIV.

Long-term care pharmacies' current prescription drug reimbursement model may not be sustainable, a new analysis suggests.

Concerns raised from combining medical marijuana dispensaries with recreational dispensaries.

Latest news in cancer drug development.

Patients treated with HIV therapy less likely to get infected with HBV.

Rollator produces highest walk distance and times in COPD patients.

Ixazomib is an oral proteasome inhibitor used in combination with lenalidomide and dexamethasone.

Patients on Medicaid more likely to have HCV infection and much more likely to be denied coverage.

Top stories of the week on Specialty Pharmacy Times.

Study suggests increasing oxidative stress through with pro-oxidants may prevent metastasis.

Quality of life after surgical treatment is an important part of recovery.

A majority of life sciences companies are planning on acquisitions and are targeting companies with a personalized medicine focus.

Legislators evaluate negotiation and pricing practices in the pharmacy industry.

Women with type 2 diabetes have greater difficulty with exercise than those without the condition.

Specialty drugs for chronic, rare, and genetic diseases are forecast to drive a $298 billion increase in brand spending.

Treatment helps reduce infection risk from low white blood cell count in cancer patients receiving chemotherapy.

Molecular mechanisms behind acute myeloid leukemia may offer a new target for drug development.